Skip to main content

BFC Planning, Inc.

SEC CIK
0002160654
Latest filing
Nov 13, 2026

The latest 13F from BFC Planning, Inc. covers Q3 2026 (filed Nov 13, 2026): 3,458 long positions worth $2.55B. The top 10 holdings make up 23.5% of the portfolio, and the largest is NVIDIA Corp (NVDA) at 5.7%. Livermore has 9 filings on Form 13F from this institution, going back to Q3 2024.

What changed in Q3 2026

Full comparison

Share counts compared with Q2 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

New
238
Est. +$25.4M
Added
1156
Est. +$337.1M
Reduced
1018
Est. −$251.7M
Sold out
197
Est. −$12.3M

Top 5 holdings

Share of this quarter's portfolio value

  1. NVDANVIDIA Corp
    5.7%$146.1MHistory
  2. Invesco QQQ Trust Series I46090E103
    3.8%$96.4M
  3. AAPLApple Inc.
    3.5%$90.1MHistory
  4. MSFTMicrosoft Corp
    2.2%$55.3MHistory
  5. SPYSPDR S&P 500 ETF Trust
    1.9%$48.2MHistory

Share of portfolio

Top 5 holdings and the other 3,453 positions, by share of portfolio value

  1. NVDA5.7%
  2. Invesco QQQ Trust Series I3.8%
  3. AAPL3.5%
  4. MSFT2.2%
  5. SPY1.9%
  6. Other 3,453 positions82.9%

Biggest buys

New and added positions, by estimated amount bought

  1. AAPLApple Inc.
    +$29.7MAddedHistory
  2. AMZNAmazon Com Inc
    +$13.9MAddedHistory
  3. ADPTAdaptive Biotechnologies Corp
    +$13.4MAddedHistory
  4. Invesco QQQ Trust Series I46090E103
    +$12.9MAdded
  5. BRK.BBerkshire Hathaway Inc
    +$10.9MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. AAPLApple Inc.
    +1.39 pp2.1% → 3.5%History
  2. AMZNAmazon Com Inc
    +0.55 pp1.0% → 1.6%History
  3. ADPTAdaptive Biotechnologies Corp
    +0.53 pp<0.1% → 0.5%History
  4. BRK.BBerkshire Hathaway Inc
    +0.41 pp0.5% → 0.9%History
  5. Invesco QQQ Trust Series I46090E103
    +0.40 pp3.4% → 3.8%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. APHAmphenol Corp
    −$10.6MReducedConverted for a 2-for-1 splitHistory
  2. iShares Russell 2000 ETF464287655
    −$10.1MReduced
  3. iShares S&P Small-Cap 600 Value ETF464287879
    −$10.1MReduced
  4. ARWRArrowhead Pharmaceuticals, Inc.
    −$9.64MReducedHistory
  5. ALKSAlkermes plc.
    −$8.29MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. iShares Russell 2000 ETF464287655
    −0.49 pp0.9% → 0.4%
  2. ARWRArrowhead Pharmaceuticals, Inc.
    −0.49 pp0.5% → <0.1%History
  3. iShares S&P Small-Cap 600 Value ETF464287879
    −0.46 pp0.7% → 0.3%
  4. APHAmphenol Corp
    −0.46 pp0.5% → <0.1%History
  5. ALKSAlkermes plc.
    −0.44 pp0.4% → <0.1%History

Metrics

13F metrics for Q3 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$2.55B
+$94.2M (+3.8%) vs. prior quarter
Positions
3,458
+41 vs. prior quarter
Top 10 concentration
23.5%
Top 10 as share of value
Turnover
10.5%
Q3 2026, one quarter
Average holding period
8.5 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q3 2024), so positions held before then are understated.

13F filings by quarter

9 quarters, going back to Q3 2024. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $2.55B (Q3 2026)

Q3 2024: $1.14BQ4 2024: $1.20BQ1 2025: $1.13BQ2 2025: $1.27BQ3 2025: $1.38BQ4 2025: $2.26BQ1 2026: $2.24BQ2 2026: $2.46BQ3 2026: $2.55B
Q3 2024Q3 2026
13F filings of BFC Planning, Inc. by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q3 2026Nov 13, 20263,458$2.55BNVDAInvesco QQQ Trust Series IAAPLvs. Q2 2026SEC
Q2 2026Oct 29, 20263,417$2.46BNVDAInvesco QQQ Trust Series IAAPLvs. Q1 2026SEC
Q1 2026Oct 29, 20263,031$2.24BNVDAInvesco QQQ Trust Series IState Street SPDR Bloomberg 1-3 Month T-Bill ETFvs. Q4 2025SEC
Q4 2025Oct 29, 20263,215$2.26BNVDAInvesco QQQ Trust Series IAAPLvs. Q3 2025SEC
Q3 2025Oct 29, 20262,888$1.38BNVDAInvesco QQQ Trust Series IAAPLvs. Q2 2025SEC
Q2 2025Oct 29, 20262,656$1.27BNVDAInvesco QQQ Trust Series IAAPLvs. Q1 2025SEC
Q1 2025Oct 29, 20262,658$1.13BNVDAAAPLInvesco QQQ Trust Series Ivs. Q4 2024SEC
Q4 2024Oct 29, 20262,599$1.20BNVDAAAPLInvesco QQQ Trust Series Ivs. Q3 2024SEC
Q3 2024Nov 13, 20262,602$1.14BNVDAAAPLInvesco QQQ Trust Series I–SEC